Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 17
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A Novel Splicing Variant in Atypical Presentation of Familial Frontotemporal Lobar Degeneration

  • Rubio Guerra, Sara|||0000-0001-7652-8029
  • Bernal, Sara|||0000-0003-4427-0574
  • Almenta Gallego, David|||0000-0001-9069-8948
  • Perez Blanco, Josefina|||0000-0002-6489-8871
  • Camacho, Valle|||0000-0003-0748-0847
  • Sala Matavera, Isabel|||0000-0002-9886-4792
  • Sánchez-Saudinós, María Belén|||0000-0003-1795-1833
  • Garcia Castro, Jesús|||0000-0003-1503-4775
  • Selma Gonzalez, Judit|||0009-0006-1021-4653
  • Santos Santos, Miguel Ángel|||0000-0003-1567-617X
  • Carbayo Viejo, Álvaro|||0000-0001-9282-8603
  • Turon-Sans, Janina|||0000-0002-8842-4646
  • Rojas-Garcia, Ricard|||0000-0003-1411-5573
  • Alcolea, Daniel|||0000-0002-3819-3245
  • Fortea, Juan|||0000-0002-1340-638X
  • Lleó, Alberto|||0000-0002-2568-5478
  • Dols Icardo, Oriol|||0000-0003-2656-8748
  • Illán-Gala, Ignacio|||0000-0002-5418-2052
C-truncating variants in the charged multivesicular body protein 2B (CHMP2B) gene are a rare cause of frontotemporal lobar degeneration (FTLD), previously identified only in Denmark, Belgium, and China. We report a novel CHMP2B splice-site variant (c.35-1G>A) associated with familial FTLD in Spain. The cases were two monozygotic male twins who presented at ages 62 and 66 years with a slowly progressive behavioral variant of frontotemporal dementia and a syndrome mimicking dementia with Lewy bodies, respectively. Functional and in silico analyses supported the pathogenicity of this variant. Our findings contribute new insights into the genetic landscape and clinical heterogeneity of FTLD.
Repisalud
Publicación Artículo científico (JournalArticle)

Associations between Urinary Phthalate Metabolites with BDNF and Behavioral Function among European Children from Five HBM4EU Aligned Studies

  • Salamanca-Fernández, Elena
  • Espín-Moreno, Lydia
  • Olivas-Martínez, Alicia
  • Pérez-Cantero, Ainhoa
  • Martín-Rodríguez, José L
  • Poyatos, Rafael M
  • Barbone, Fabio
  • Rosolen, Valentina
  • Mariuz, Marika
  • Ronfani, Luca
  • Palkovicova Murinova, Lubica
  • Fábelová, Lucia
  • Szigeti, Tamás
  • Kakucs, Réka
  • Sakhi, Amrit K
  • Haug, Line S
  • Lindeman, Birgitte
  • Snoj Tratnik, Janja
  • Kosjek, Tina
  • Jacobs, Griet
  • Voorspoels, Stefan
  • Jurdáková, Helena
  • Górová, Renáta
  • Petrovičová, Ida
  • Kolena, Branislav
  • Esteban-Lopez, Marta
  • Pedraza-Diaz, Susana
  • Kolossa-Gehring, Marike
  • Remy, Sylvie
  • Govarts, Eva
  • Schoeters, Greet
  • Fernández, Mariana F
  • Mustieles, Vicente
Based on toxicological evidence, children's exposure to phthalates may contribute to altered neurodevelopment and abnormal regulation of brain-derived neurotrophic factor (BDNF). We analyzed data from five aligned studies of the Human Biomonitoring for Europe (HBM4EU) project. Ten phthalate metabolites and protein BDNF levels were measured in the urine samples of 1148 children aged 6-12 years from Italy (NACII-IT cohort), Slovakia (PCB-SK cohort), Hungary (InAirQ-HU cohort) and Norway (NEBII-NO). Serum BDNF was also available in 124 Slovenian children (CRP-SLO cohort). Children's total, externalizing and internalizing behavioral problems were assessed using the Child Behavior Checklist at 7 years of age (only available in the NACII-IT cohort). Adjusted linear and negative binomial regression models were fitted, together with weighted quantile sum (WQS) regression models to assess phthalate mixture associations. Results showed that, in boys but not girls of the NACII-IT cohort, each natural-log-unit increase in mono-n-butyl phthalate (MnBP) and Mono(2-ethyl-5-oxohexyl) phthalate (MEOHP) was cross-sectionally associated with higher externalizing problems [incidence rate ratio (IRR): 1.20; 95% CI: 1.02, 1.42 and 1.26; 95% CI: 1.03, 1.55, respectively]. A suggestive mixture association with externalizing problems was also observed per each tertile mixture increase in the whole population (WQS-IRR = 1.15; 95% CI: 0.97, 1.36) and boys (IRR = 1.20; 95% CI: 0.96, 1.49). In NACII-IT, PCB-SK, InAirQ-HU and NEBII-NO cohorts together, urinary phthalate metabolites were strongly associated with higher urinary BDNF levels, with WQS regression confirming a mixture association in the whole population (percent change (PC) = 25.9%; 95% CI: 17.6, 34.7), in girls (PC = 18.6%; 95% CI: 7.92, 30.5) and mainly among boys (PC = 36.0%; 95% CI: 24.3, 48.9). Among CRP-SLO boys, each natural-log-unit increase in ∑DINCH concentration was associated with lower serum BDNF levels (PC: -8.8%; 95% CI: -16.7, -0.3). In the NACII-IT cohort, each natural-log-unit increase in urinary BDNF levels predicted worse internalizing scores among all children (IRR: 1.15; 95% CI: 1.00, 1.32). Results suggest that (1) children's exposure to di-n-butyl phthalate (DnBP) and di(2-ethylhexyl) phthalate (DEHP) metabolites is associated with more externalizing problems in boys, (2) higher exposure to DINCH may associate with lower systemic BDNF levels in boys, (3) higher phthalate exposure is associated with higher urinary BDNF concentrations (although caution is needed since the possibility of a "urine concentration bias" that could also explain these associations in noncausal terms was identified) and (4) higher urinary BDNF concentrations may predict internalizing problems. Given this is the first study to examine the relationship between phthalate metabolite exposure and BDNF biomarkers, future studies are needed to validate the observed associations.
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publicación Artículo científico (JournalArticle)

Edelfosine nanoemulsions inhibit tumor growth of triple negative breast cancer in zebrafish xenograft model

  • Gutiérrez Lovera, Carlha
  • Martinez-Val, Jeannette
  • Lores Touriño, Sainza
  • López Bouzo, Belén
  • Díez Villares, Sandra
  • Sandra, Alijas Pérez
  • Pensado López, Alba
  • Vázquez Ríos, Abi Judit
  • Sánchez Piñón, Laura
  • Fuente Freire, María de la
  • Saraiva, Sofía M.
Triple negative breast cancer (TNBC) is known for being very aggressive, heterogeneous and highly metastatic. The standard of care treatment is still chemotherapy, with adjacent toxicity and low efficacy, highlighting the need for alternative and more effective therapeutic strategies. Edelfosine, an alkyl-lysophospholipid, has proved to be a promising therapy for several cancer types, upon delivery in lipid nanoparticles. Therefore, the objective of this work was to explore the potential of edelfosine for the treatment of TNBC. Edelfosine nanoemulsions (ET-NEs) composed by edelfosine, Miglyol 812 and phosphatidylcholine as excipients, due to their good safety profile, presented an average size of about 120 nm and a neutral zeta potential, and were stable in biorelevant media. The ability of ET-NEs to interrupt tumor growth in TNBC was demonstrated both in vitro, using a highly aggressive and invasive TNBC cell line, and in vivo, using zebrafish embryos. Importantly, ET-NEs were able to penetrate through the skin barrier of MDA-MB 231 xenografted zebrafish embryos, into the yolk sac, leading to an effective decrease of highly aggressive and invasive tumoral cells’ proliferation. Altogether the results demonstrate the potential of ET-NEs for the development of new therapeutic approaches for TNBC
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

NRF2 deficit prevents pathologic Tau seeding and spreading in an induced tauopathy mouse model

  • López-Sampere, Yaiza
  • Mengod Soler, Pol
  • Roca-Pereira, Sergio
  • Vinyals, Antonia
  • Mato-Blanco, Xoel
  • Vela-Martínez, Marta
  • Dakterzada, Farida
  • Romero, Leila
  • Santamaría Martínez, Enrique
  • Fernández Irigoyen, Joaquín
  • Ferrer, Isidro
  • Povedano, Mónica
  • Río, José Antonio del
  • Santpere, Gabriel
  • Portero-Otín, Manuel
  • Piñol-Ripoll, Gerard
  • Andrés Benito, Pol
Background. Nuclear factor erythroid 2–related factor 2 (NRF2) regulates antioxidant defenses and protects against neurodegeneration, including Alzheimer's disease (AD). Its age-related decline disrupts redox balance and increases neuronal vulnerability, but the early hippocampal effects remain unclear. Here, we tested whether NRF2 loss affects tau seeding and spreading in a PHF-tau–inoculated mouse model, contributing to accelerated aging. Methodology. Three-month-old NRF2-knockout (Nfe2l2−/−) and wild-type (WT) mice received hippocampal inoculations of human AD-derived PHF-tau, and tau propagation was analyzed after three months. To elucidate the molecular underpinnings of the observed changes, we performed integrative phosphoproteotranscriptomic analyses of hippocampal tissue, supported by RT-qPCR and Western blot validation. Results. PHF-tau inoculation at 3 months of age in Nfe2l2−/− mice, surprisingly, exhibited markedly reduced tau seeding and spreading compared to WT after 3 months of incubation. Molecular characterization of the Nfe2l2−/− hippocampus was carried out to unravel the molecular changes associated with impaired tau propagation. Transcriptomic profiling revealed 745 deregulated genes in Nfe2l2−/− mice, characterized by upregulation of immune and metabolic pathways but downregulation of oxidative stress and redox-related genes. RT-qPCR confirmed diminished expression of antioxidant enzymes and anti-inflammatory receptors, alongside altered astrocytic markers. Proteomic analysis identified 157 dysregulated proteins associated with mitochondrial, synaptic, and inflammatory processes, while phosphoproteomics detected 824 altered phosphosites enriched in cytoskeletal and synaptic networks. Western blot showed increased GFAP-C-term, AQP4, 8-OHdG, and MDAL, with reduced GSTM2 expression. Notably, total and 4R-tau levels were decreased, while 3R-tau was elevated in Nfe2l2−/− mice. Conclusion. Our findings suggest that NRF2 loss induces a hippocampal state marked by impaired antioxidant defenses, astrocytic remodeling, and disrupted tau isoform balance. This environment, while metabolically altered, paradoxically hinders tau propagation, highlighting NRF2 as a key regulator of both redox and cellular maturity programs essential for tau spread and as a potential therapeutic target in tauopathies., MPO was supported by grants from the Instituto de Salud Carlos III (PI20/000155, PI23/00176), and PAB was supported by grants from the same governmental institution (CD23/00097). The project that gave rise to these results received the support of a fellowship to PMS from Fundación Ramón Areces. We want to particularly acknowledge patients and Biobank HUB-ICO-IDIBELL (PT20/00171) integrated in the ISCIII Biobanks and Biomodels Platform and Xarxa Banc de Tumors de Catalunya (XBTC) for their collaboration. We thank CERCA Programme/Generalitat de Catalunya for institutional support.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

TDP-43 regulates LC3ylation in neural tissue through ATG4B cryptic splicing inhibition

  • Torres, Pascual
  • Rico-Ríos, Santiago
  • Ceron-Codorniu, Miriam
  • Santacreu-Vilaseca, Marta
  • Seoane-Miraz, David
  • Jad, Yahya
  • Ayala, Victòria
  • Mariño, Guillermo
  • Beltrán, Maria
  • Miralles, Maria P.
  • Andrés Benito, Pol
  • Fernández Irigoyen, Joaquín
  • Santamaría Martínez, Enrique
  • López-Otín, Carlos
  • Soler, Rosa M.
  • Povedano, Mónica
  • Ferrer, Isidro
  • Pamplona, Reinald
  • Wood, Matthew J. A.
  • Varela, Miguel A.
  • Portero-Otín, Manuel
Amyotrophic lateral sclerosis (ALS) is an adult-onset motor neuron disease with a mean survival time of three years. The 97% of the cases have TDP-43 nuclear depletion and cytoplasmic aggregation in motor neurons. TDP-43 prevents non-conserved cryptic exon splicing in certain genes, maintaining transcript stability, including ATG4B, which is crucial for autophagosome maturation and Microtubule-associated proteins 1A/1B light chain 3B (LC3B) homeostasis. In ALS mice (G93A), Atg4b depletion worsens survival rates and autophagy function. For the first time, we observed an elevation of LC3ylation in the CNS of both ALS patients and atg4b−/− mouse spinal cords. Furthermore, LC3ylation modulates the distribution of ATG3 across membrane compartments. Antisense oligonucleotides (ASOs) targeting cryptic exon restore ATG4B mRNA in TARDBP knockdown cells. We further developed multi-target ASOs targeting TDP-43 binding sequences for a broader effect. Importantly, our ASO based in peptide-PMO conjugates show brain distribution post-IV administration, offering a non-invasive ASO-based treatment avenue for neurodegenerative diseases., Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature. G.M. was supported by grants from Ministerio Ciencia e Innovación (Spain) (PID2021-127534OB-I00). M.P.-O. and R.M.S. were supported by grants from Instituto de Salud Carlos III (PI20/000155, PI23/00176 and PI20/00098). R.P. was supported by Generalitat de Catalunya (2021 SGR 00990). P.T. was supported by an Unzué-Luzón grant. P.T. received a Margarita Salas postdoctoral fellowship from the Spanish Ministry of Universities (Spanish Government) which was supported by NextGenerationEU. Work supported by IRBLleida Scientific and Technical Service of Immunohistochemistry.
RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Publicación Artículo científico (JournalArticle)

Razonamiento de profesorado de Educación Primaria en Formación Inicial sobre la controversia sociocientífica “leche materna versus leche de fórmula”. Influencia de una propuesta formativa, Reasoning of preservice elementary education teachers on the socioscientific controversy "breastfeeding versus formula milk". Influence of an instructional module

  • Palma-Jiménez, Miriam
  • Cebrián Robles, Daniel
  • Blanco López, Ángel
La lactancia humana presenta características propias de los problemas sociocientíficos, identificando en ella diferentes controversias, entre las que se encuentra la relativa al uso de leche materna o de fórmula. En este trabajo se analiza la influencia de una propuesta formativa, que combina tres estrategias didácticas, análisis de etiquetas, juego de rol y mapeo de controversia, en el razonamiento de 62 profesores y profesoras de Educación Primaria en formación inicial sobre dicha controversia. Para ello, se utilizó como pretest y postest una tarea en la que se les pedía su posición razonada sobre qué modelo de lactancia es mejor: con leche materna o de fórmula. Los resultados obtenidos muestran que la propuesta formativa ha influido en el número de razones y en los tipos de razonamiento realizado por los participantes, pero no en las posiciones con respecto a la controversia, que de partida eran claramente a favor de la leche materna. Igualmente, se encuentra un aumento significativo en el número de razones que muestran un conocimiento científico adecuado. Finalmente, se plantean algunas implicaciones didácticas y otras para continuar la investigación, Human breastfeeding presents characteristics of socioscientific problems, identifying in it different controversies, among which is the one related to the use of breast milk or formula milk. This paper analyzes the influence of an instructional module, which combines three teaching strategies: label analysis, role-playing and controversy mapping, on the reasoning of 62 preservice elementary teachers on this controversy. For this purpose, a pretest and posttest task were used asking for their reasoned position on which breastfeeding model is better: with breast milk or formula milk. The instructional module has influenced the number of reasons and the types of reasoning made by the participants, but not their positions with respect to the controversy, which were clearly in favor of breast milk. Likewise, a significant increase is found in the number of reasons showing adequate scientific knowledge. Finally, some teaching and other implications for further research are raised.
RUA. Repositorio Institucional de la Universidad de Alicante
Publicación Otros (Other)

La potencia estadística prospectiva del voto retrospectivo en España (1996-2015), The prospective statistical power of the retrospective vote in Spain (1996-2015)

  • Alaminos, Antonio
  • Alaminos, Paloma
  • Alaminos, Antonio|||/items/c1566d1b-8a36-4b23-b5fc-bf1fd4ed0e4e
Esta investigación evalúa la capacidad explicativa y predictiva que la valoración de la actuación/gestión del PP y el PSOE tiene sobre los resultados electorales de estos partidos. La valoración de los dos partidos se efectúa de forma anticipada, entre uno y dos meses antes de las elecciones. El diseño incluye conjuntamente ambos partidos, por lo que la hipótesis testada es acerca de la relación entre valoración de la actuación y gestión de los partidos y sus resultados electorales (Downs, 1957). Es decir, la eficacia del modelo de voto retrospectivo para explicar y anticipar los resultados electorales en elecciones generales en España. Las convocatorias estudiadas son las elecciones generales en España del 1996, 2000, 2004, 2008, 2011 y 2015. Los datos de valoración proceden del Centro de Investigaciones Sociológicas y los resultados electorales del Ministerio del Interior. Tras testar las hipótesis de asociación y de dependencia entre el voto retrospectivo anticipado y los resultados electorales, se concluye que el indicador de valoración de la actuación/gestión del PP y el PSOE tiene, con carácter anticipado de uno a dos meses, una asociación y capacidad explicativa significativa de los resultados electorales. La potencia predictiva, por el contrario, no es limitada al considerar por razones de tamaño muestral en el mismo modelo los resultados de los dos partidos. Asimismo, se efectúa un análisis de la potencia estadística de varios modelos, comparando diferentes especificaciones.
RUA. Repositorio Institucional de la Universidad de Alicante
Publicación Otros (Other)

Las dinámicas del voto retrospectivo en España (1996-2017)

  • Alaminos, Antonio
  • Alaminos, Paloma
  • Alaminos, Antonio|||/items/c1566d1b-8a36-4b23-b5fc-bf1fd4ed0e4e
Tras introducir brevemente algunos conceptos explicativos del voto desde el punto de vista de su influencia a largo, medio y corto plazo, se efectúa un análisis desde el enfoque del modelo de voto retrospectivo. Se analizan cuatro series del banco de datos del Centro de Investigaciones Sociológicas, con la valoración de la gestión/actuación del Partido Popular y del Partido Socialista Obrero Español, así como las series de intención de voto a los dos partidos. Del análisis se concluye la estrecha relación existente entre la valoración de la gestión/actuación de ambos partidos con su intención de voto. Las tendencias de declive observadas en la confianza en la gestión/actuación de los dos partidos anticipaban el escenario de crisis del bipartidismo de 2015, sugiriendo su incorporación como elemento de su «imagen de partido». Así mismo, considerando las dinámicas para los dos partidos, se observa la anomalía que, dentro de la pauta general, representan las elecciones generales de 2004 y 2011. Como estrategia de control de la falacia ecológica de los agregados, se ha efectuado un control en cinco años (1997, 2002, 2007, 2012 y 2017) analizando los microdatos para establecer la relación entre valoración de la gestión/actuación del partido y su intención de voto en la unidad de análisis individual.
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Exploring platelet metabolomics and fatty acid profiles for ALS prognosis and diagnosis

  • Torres Cabestany, Pascual
  • Pradas, Irene
  • Fernández Bernal, Anna
  • Povedano, Mònica
  • Dominguez, Raul
  • Jové Font, Mariona
  • González Mingot, Cristina
  • Ayala Jové, Ma. Victoria (Maria Victoria)
  • Ferrer, Isidre
  • Pamplona Gras, Reinald
  • Portero Otín, Manuel
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with heterogeneous clinical progression, reflecting distinct underlying pathological mechanisms. Early and accurate diagnosis and prognosis require reliable biomarkers to improve clinical management and therapeutic stratification. The present study explores the potential of platelet global metabolomics and fatty acid (FA) profiling as potential sources of diagnostic and prognostic biomarkers for ALS. We analysed platelets from 15 recently diagnosed ALS patients and 21 healthy controls (CTLs) using liquid chromatography-mass spectrometry (LC-MS) for metabolomics and gas chromatography-flame ionization detection (GC-FID) for FA profiling. ALS patients were classified as fast or slow progressors based on the median ALS Functional Rating Scale-Revised (ALSFRS-R) slope. While global metabolomic and FA profiles have shown limited potential for distinguishing ALS from CTL, preliminary molecular annotation based on mass and retention times disclosed specific metabolites with potential diagnostic value. Importantly, both global metabolomic and FA analyses demonstrated a marked capacity to differentiate fast progressors from slow progressors (receiver operating characteristic (ROC) curves of approximately 1), revealing distinct metabolic signatures associated with disease progression. Our findings demonstrate that platelet global metabolomics and FA profiling hold promise as prognostic biomarkers in ALS., We acknowledge funding from the Spanish Ministry of Economy and Competitiveness, Institute of Health Carlos III (PI20/0155; PI23/00176) to MP-O; from the Spanish Ministry of Science, Innovation and Universities (RTI2018-099200-B-I00), and the Generalitat of Catalonia (Agency for Management of University and Research Grants (2017SGR696) and Department of Health (SLT002/16/00250)) to RP. Support was also received in the form of a FUNDELA Grant, RedELA-Plataforma Investigación, and the Fundació Miquel Valls (Jack Van den Hoek donation). M.J, is a professor under the Serra Hunter program (Generalitat de Catalunya). This study has been co-financed by FEDER funds from the European Union (“A way to build Europe”) and funded by the PIRS program by the “Diputació de Lleida” and by the “la Caixa” Foundation. IRBLleida is funded by a CERCA Programme/Generalitat of Catalonia. P.T. received a Margarita Salas postdoctoral fellowship from the Spanish Ministry of Universities (Spanish Government), which was supported by NextGenerationEU. P.T. received a Beatriu de Pinós postdoctoral fellowship from the Departament de Recerca i Universitats de la Generalitat de Catalunya (2023 BP 00144).
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

NRF2 deficit prevents pathologic Tau seeding and spreading in an induced tauopathy mouse model

  • López Sampere, Yaiza
  • Mengod Soler, Pol
  • Roca Pereira, Sergio
  • Vinyals, Antonia
  • Mato Blanco, Xoel
  • Vela Martínez, Marta
  • Dakterzada, Farida
  • Romero El Khayat, Leila
  • Santamaría, Enrique
  • Fernández Irigoyen, Joaquín
  • Ferrer, Isidro
  • Povedano, Mónica
  • Del Rio, José Antonio
  • Santpere, Gabriel
  • Portero Otín, Manuel
  • Piñol Ripoll, Gerard
  • Andrés Benito, Pol
Background Nuclear factor erythroid 2–related factor 2 (NRF2) regulates antioxidant defenses and protects against neurodegeneration, including Alzheimer's disease (AD). Its age-related decline disrupts redox balance and increases neuronal vulnerability, but the early hippocampal effects remain unclear. Here, we tested whether NRF2 loss affects tau seeding and spreading in a PHF-tau–inoculated mouse model, contributing to accelerated aging. Methodology Three-month-old NRF2-knockout (Nfe2l2−/−) and wild-type (WT) mice received hippocampal inoculations of human AD-derived PHF-tau, and tau propagation was analyzed after three months. To elucidate the molecular underpinnings of the observed changes, we performed integrative phosphoproteotranscriptomic analyses of hippocampal tissue, supported by RT-qPCR and Western blot validation. Results PHF-tau inoculation at 3 months of age in Nfe2l2−/− mice, surprisingly, exhibited markedly reduced tau seeding and spreading compared to WT after 3 months of incubation. Molecular characterization of the Nfe2l2−/− hippocampus was carried out to unravel the molecular changes associated with impaired tau propagation. Transcriptomic profiling revealed 745 deregulated genes in Nfe2l2−/− mice, characterized by upregulation of immune and metabolic pathways but downregulation of oxidative stress and redox-related genes. RT-qPCR confirmed diminished expression of antioxidant enzymes and anti-inflammatory receptors, alongside altered astrocytic markers. Proteomic analysis identified 157 dysregulated proteins associated with mitochondrial, synaptic, and inflammatory processes, while phosphoproteomics detected 824 altered phosphosites enriched in cytoskeletal and synaptic networks. Western blot showed increased GFAP-C-term, AQP4, 8-OHdG, and MDAL, with reduced GSTM2 expression. Notably, total and 4R-tau levels were decreased, while 3R-tau was elevated in Nfe2l2−/− mice. Conclusion Our findings suggest that NRF2 loss induces a hippocampal state marked by impaired antioxidant defenses, astrocytic remodeling, and disrupted tau isoform balance. This environment, while metabolically altered, paradoxically hinders tau propagation, highlighting NRF2 as a key regulator of both redox and cellular maturity programs essential for tau spread and as a potential therapeutic target in tauopathies., MPO was supported by grants from the Instituto de Salud Carlos III (PI20/000155, PI23/00176), and PAB was supported by grants from the same governmental institution (CD23/00097). The project that gave rise to these results received the support of a fellowship to PMS from Fundaci´on Ram´on Areces. We want to particularly acknowledge patients and Biobank HUB-ICO-IDIBELL (PT20/00171) integrated in the ISCIII Biobanks and Biomodels Platform and Xarxa Banc de Tumors de Cata lunya (XBTC) for their collaboration. We thank CERCA Programme/ Generalitat de Catalunya for institutional support.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

NRF2 deficit prevents pathologic Tau seeding and spreading in an induced tauopathy mouse model

  • López Sampere, Yaiza
  • Mengod Soler, Pol
  • Roca Pereira, Sergio
  • Vinyals, Antonia
  • Mato Blanco, Xoel
  • Vela Martínez, Marta
  • Dakterzada, Farida
  • Romero El Khayat, Leila
  • Santamaría, Enrique
  • Fernández Irigoyen, Joaquín
  • Ferrer, Isidro
  • Povedano, Mónica
  • Del Rio, José Antonio
  • Santpere, Gabriel
  • Portero Otín, Manuel
  • Piñol Ripoll, Gerard
  • Andrés Benito, Pol
Background Nuclear factor erythroid 2–related factor 2 (NRF2) regulates antioxidant defenses and protects against neurodegeneration, including Alzheimer's disease (AD). Its age-related decline disrupts redox balance and increases neuronal vulnerability, but the early hippocampal effects remain unclear. Here, we tested whether NRF2 loss affects tau seeding and spreading in a PHF-tau–inoculated mouse model, contributing to accelerated aging. Methodology Three-month-old NRF2-knockout (Nfe2l2−/−) and wild-type (WT) mice received hippocampal inoculations of human AD-derived PHF-tau, and tau propagation was analyzed after three months. To elucidate the molecular underpinnings of the observed changes, we performed integrative phosphoproteotranscriptomic analyses of hippocampal tissue, supported by RT-qPCR and Western blot validation. Results PHF-tau inoculation at 3 months of age in Nfe2l2−/− mice, surprisingly, exhibited markedly reduced tau seeding and spreading compared to WT after 3 months of incubation. Molecular characterization of the Nfe2l2−/− hippocampus was carried out to unravel the molecular changes associated with impaired tau propagation. Transcriptomic profiling revealed 745 deregulated genes in Nfe2l2−/− mice, characterized by upregulation of immune and metabolic pathways but downregulation of oxidative stress and redox-related genes. RT-qPCR confirmed diminished expression of antioxidant enzymes and anti-inflammatory receptors, alongside altered astrocytic markers. Proteomic analysis identified 157 dysregulated proteins associated with mitochondrial, synaptic, and inflammatory processes, while phosphoproteomics detected 824 altered phosphosites enriched in cytoskeletal and synaptic networks. Western blot showed increased GFAP-C-term, AQP4, 8-OHdG, and MDAL, with reduced GSTM2 expression. Notably, total and 4R-tau levels were decreased, while 3R-tau was elevated in Nfe2l2−/− mice. Conclusion Our findings suggest that NRF2 loss induces a hippocampal state marked by impaired antioxidant defenses, astrocytic remodeling, and disrupted tau isoform balance. This environment, while metabolically altered, paradoxically hinders tau propagation, highlighting NRF2 as a key regulator of both redox and cellular maturity programs essential for tau spread and as a potential therapeutic target in tauopathies., MPO was supported by grants from the Instituto de Salud Carlos III (PI20/000155, PI23/00176), and PAB was supported by grants from the same governmental institution (CD23/00097). The project that gave rise to these results received the support of a fellowship to PMS from Fundaci´on Ram´on Areces. We want to particularly acknowledge patients and Biobank HUB-ICO-IDIBELL (PT20/00171) integrated in the ISCIII Biobanks and Biomodels Platform and Xarxa Banc de Tumors de Cata lunya (XBTC) for their collaboration. We thank CERCA Programme/ Generalitat de Catalunya for institutional support.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Exploring platelet metabolomics and fatty acid profiles for ALS prognosis and diagnosis

  • Torres Cabestany, Pascual
  • Pradas, Irene
  • Fernández Bernal, Anna
  • Povedano, Mònica
  • Dominguez, Raul
  • Jové Font, Mariona
  • González Mingot, Cristina
  • Ayala Jové, Ma. Victoria (Maria Victoria)
  • Ferrer, Isidre
  • Pamplona Gras, Reinald
  • Portero Otín, Manuel
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with heterogeneous clinical progression, reflecting distinct underlying pathological mechanisms. Early and accurate diagnosis and prognosis require reliable biomarkers to improve clinical management and therapeutic stratification. The present study explores the potential of platelet global metabolomics and fatty acid (FA) profiling as potential sources of diagnostic and prognostic biomarkers for ALS. We analysed platelets from 15 recently diagnosed ALS patients and 21 healthy controls (CTLs) using liquid chromatography-mass spectrometry (LC-MS) for metabolomics and gas chromatography-flame ionization detection (GC-FID) for FA profiling. ALS patients were classified as fast or slow progressors based on the median ALS Functional Rating Scale-Revised (ALSFRS-R) slope. While global metabolomic and FA profiles have shown limited potential for distinguishing ALS from CTL, preliminary molecular annotation based on mass and retention times disclosed specific metabolites with potential diagnostic value. Importantly, both global metabolomic and FA analyses demonstrated a marked capacity to differentiate fast progressors from slow progressors (receiver operating characteristic (ROC) curves of approximately 1), revealing distinct metabolic signatures associated with disease progression. Our findings demonstrate that platelet global metabolomics and FA profiling hold promise as prognostic biomarkers in ALS., We acknowledge funding from the Spanish Ministry of Economy and Competitiveness, Institute of Health Carlos III (PI20/0155; PI23/00176) to MP-O; from the Spanish Ministry of Science, Innovation and Universities (RTI2018-099200-B-I00), and the Generalitat of Catalonia (Agency for Management of University and Research Grants (2017SGR696) and Department of Health (SLT002/16/00250)) to RP. Support was also received in the form of a FUNDELA Grant, RedELA-Plataforma Investigación, and the Fundació Miquel Valls (Jack Van den Hoek donation). M.J, is a professor under the Serra Hunter program (Generalitat de Catalunya). This study has been co-financed by FEDER funds from the European Union (“A way to build Europe”) and funded by the PIRS program by the “Diputació de Lleida” and by the “la Caixa” Foundation. IRBLleida is funded by a CERCA Programme/Generalitat of Catalonia. P.T. received a Margarita Salas postdoctoral fellowship from the Spanish Ministry of Universities (Spanish Government), which was supported by NextGenerationEU. P.T. received a Beatriu de Pinós postdoctoral fellowship from the Departament de Recerca i Universitats de la Generalitat de Catalunya (2023 BP 00144).
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Modulation of colorectal tumor behavior via lncRNA TP53TG1-lipidic nanosystem

  • Masoumi, Farimah
  • Saraiva, Sofia M.
  • Bouzo, Belén L.
  • López-López, Rafael|||0000-0002-2240-6277
  • Esteller, M|||0000-0003-4490-6093
  • Diaz-Lagares, Angel|||0000-0002-9114-9227
  • de la Fuente, María
Long non-coding RNAs (lncRNAs) are an emerging group of RNAs with a crucial role in cancer pathogenesis. In gastrointestinal cancers, TP53 target 1 (TP53TG1) is an epigenetically regulated lncRNA that represents a promising therapeutic target due to its tumor suppressor properties regulating the p53-mediated DNA damage and the intracellular localization of the oncogenic YBX1 protein. However, to translate this finding into the clinic as a gene therapy, it is important to develop effective carriers able to deliver exogenous lncRNAs to the targeted cancer cells. Here, we propose the use of biocompatible sphingomyelin nanosystems comprising DOTAP (DSNs) to carry and deliver a plasmid vector encoding for TP53TG1 (pc(TP53TG1)-DSNs) to a colorectal cancer cell line (HCT-116). DSNs presented a high association capacity and convenient physicochemical properties. In addition, pc(TP53TG1)-DSNs showed anti-tumor activities in vitro, specifically a decrease in the proliferation rate, a diminished colony-forming capacity, and hampered migration and invasiveness of the treated cancer cells. Consequently, the proposed strategy displays a high potential as a therapeutic approach for colorectal cancer.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Dissecting TET2 Regulatory Networks in Blood Differentiation and Cancer

  • Lazarenkov, Aleksey|||0000-0003-0652-8116
  • Sardina, José Luis|||0000-0002-8493-3937
Cytosine methylation (5mC) of CpG is the major epigenetic modification of mammalian DNA, playing essential roles during development and cancer. Although DNA methylation is generally associated with transcriptional repression, its role in gene regulation during cell fate decisions remains poorly understood. DNA demethylation can be either passive or active when initiated by TET dioxygenases. During active demethylation, transcription factors (TFs) recruit TET enzymes (TET1, 2, and 3) to specific gene regulatory regions to first catalyze the oxidation of 5mC to 5-hydroxymethylcytosine (5hmC) and subsequently to higher oxidized cytosine derivatives. Only TET2 is frequently mutated in the hematopoietic system from the three TET family members. These mutations initially lead to the hematopoietic stem cells (HSCs) compartment expansion, eventually evolving to give rise to a wide range of blood malignancies. This review focuses on recent advances in characterizing the main TET2-mediated molecular mechanisms that activate aberrant transcriptional programs in blood cancer onset and development. In addition, we discuss some of the key outstanding questions in the field.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

NOX2 control over energy metabolism plays a role in acute myeloid leukaemia prognosis and survival

  • Ijurko, Carla
  • Romo-González, Marta
  • García-Calvo, Clara
  • Sardina, José Luis|||0000-0002-8493-3937
  • Sánchez-Bernal, Carmen
  • Sánchez-Yagüe, Jesús
  • Elena-Herrmann, Bénédicte
  • Villaret, Joran
  • Garrel, Catherine
  • Mondet, Julie
  • Mossuz, Pascal
  • Hernández-Hernández, Ángel
Acute myeloid leukaemia (AML) is a highly heterogeneous disease, however the therapeutic approaches have hardly changed in the last decades. Metabolism rewiring and the enhanced production of reactive oxygen species (ROS) are hallmarks of cancer. A deeper understanding of these features could be instrumental for the development of specific AML-subtypes treatments. NADPH oxidases (NOX), the only cellular system specialised in ROS production, are also involved in leukemic metabolism control. NOX2 shows a variable expression in AML patients, so patients can be classified based on such difference. Here we have analysed whether NOX2 levels are important for AML metabolism control. The lack of NOX2 in AML cells slowdowns basal glycolysis and oxidative phosphorylation (OXPHOS), along with the accumulation of metabolites that feed such routes, and a sharp decrease of glutathione. In addition, we found changes in the expression of 725 genes. Among them, we have discovered a panel of 30 differentially expressed metabolic genes, whose relevance was validated in patients. This panel can segregate AML patients according to CYBB expression, and it can predict patient prognosis and survival. In summary, our data strongly support the relevance of NOX2 for AML metabolism, and highlights the potential of our discoveries in AML prognosis.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

The HDAC7-TET2 epigenetic axis is essential during early B lymphocyte development

  • Azagra, Alba|||0000-0002-9097-1251
  • Meler, Ainara|||0000-0002-0026-7325
  • de Barrios, Oriol|||0000-0001-5076-1455
  • Tomás Daza, Laureano|||0000-0002-6127-1694
  • Collazo, Olga
  • Monterde, B.
  • Obiols, Mireia|||0000-0003-3323-5239
  • Rovirosa Mulet, Llorenç|||0000-0003-2986-9001
  • Vila-Casadesús, Maria|||0000-0001-6597-7953
  • Cabrera Pasadas, Mònica|||0000-0001-9216-0906
  • Gusi Vives, Mar|||0000-0001-5702-153X
  • Graf, Thomas|||0000-0003-2774-4117
  • Varela, Ignacio|||0000-0002-0969-506X
  • Sardina, José Luis|||0000-0002-8493-3937
  • Javierre, B. M.|||0000-0002-8682-6748
  • Parra, Maribel|||0000-0002-9072-5763
Correct B cell identity at each stage of cellular differentiation during B lymphocyte development is critically dependent on a tightly controlled epigenomic landscape. We previously identified HDAC7 as an essential regulator of early B cell development and its absence leads to a drastic block at the pro-B to pre-B cell transition. More recently, we demonstrated that HDAC7 loss in pro-B-ALL in infants associates with a worse prognosis. Here we delineate the molecular mechanisms by which HDAC7 modulates early B cell development. We find that HDAC7 deficiency drives global chromatin de-condensation, histone marks deposition and deregulates other epigenetic regulators and mobile elements. Specifically, the absence of HDAC7 induces TET2 expression, which promotes DNA 5-hydroxymethylation and chromatin de-condensation. HDAC7 deficiency also results in the aberrant expression of microRNAs and LINE-1 transposable elements. These findings shed light on the mechanisms by which HDAC7 loss or misregulation may lead to B cell-based hematological malignancies.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

p53 rapidly restructures 3D chromatin organization to trigger a transcriptional response

  • Serra, François|||0000-0003-3895-4742
  • Nieto-Aliseda, Andrea|||0000-0002-3238-8711
  • Fanlo-Escudero, Lucía|||0000-0002-8364-9520
  • Rovirosa, Llorenç
  • Cabrera Pasadas, Mònica|||0000-0001-9216-0906
  • Lazarenkov, Aleksey|||0000-0003-0652-8116
  • Urmeneta, Blanca
  • Alcalde-Merino, Alvaro|||0000-0002-6374-2410
  • Nola, Emanuele M.
  • Okorokov, Andrei L.|||0000-0003-2477-3254
  • Fraser, Peter|||0000-0002-0041-1227
  • Graupera, Mariona|||0000-0003-4608-4185
  • Castillo, Sandra D.|||0000-0002-7007-3155
  • Sardina, José L.
  • Valencia, Alonso
  • Javierre, B. M|||0000-0002-8682-6748
Activation of the p53 tumor suppressor triggers a transcriptional program to control cellular response to stress. However, the molecular mechanisms by which p53 controls gene transcription are not completely understood. Here, we uncover the critical role of spatio-temporal genome architecture in this process. We demonstrate that p53 drives direct and indirect changes in genome compartments, topologically associating domains, and DNA loops prior to one hour of its activation, which escort the p53 transcriptional program. Focusing on p53-bound enhancers, we report 340 genes directly regulated by p53 over a median distance of 116 kb, with 74% of these genes not previously identified. Finally, we showcase that p53 controls transcription of distal genes through newly formed and pre-existing enhancer-promoter loops in a cohesin dependent manner. Collectively, our findings demonstrate a previously unappreciated architectural role of p53 as regulator at distinct topological layers and provide a reliable set of new p53 direct target genes that may help designs of cancer therapies.